Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 20,000 shares at $15.88 ($318K) on 2022-12-15, disclosed to the SEC on 2022-12-16.
Seasonal sale ($318k) by EVP, Scientific Strategy & CSO — this insider has traded EXEL in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |
| EXEL | SELL | 2021-08-18 | $2.0M | — | Filing → |